Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Coya Therapeutics (COYA) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to 0.85.

  • Coya Therapeutics' Equity Ratio fell 542.9% to 0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85, marking a year-over-year decrease of 542.9%. This contributed to the annual value of 0.89 for FY2024, which is 333.52% up from last year.
  • Per Coya Therapeutics' latest filing, its Equity Ratio stood at 0.85 for Q3 2025, which was down 542.9% from 0.85 recorded in Q2 2025.
  • Coya Therapeutics' 5-year Equity Ratio high stood at 0.93 for Q1 2023, and its period low was 1.0 during Q4 2022.
  • For the 4-year period, Coya Therapeutics' Equity Ratio averaged around 0.72, with its median value being 0.87 (2025).
  • In the last 5 years, Coya Therapeutics' Equity Ratio skyrocketed by 18638.45% in 2023 and then tumbled by 658.03% in 2024.
  • Over the past 4 years, Coya Therapeutics' Equity Ratio (Quarter) stood at 1.0 in 2022, then surged by 186.38% to 0.86 in 2023, then increased by 3.34% to 0.89 in 2024, then decreased by 4.59% to 0.85 in 2025.
  • Its last three reported values are 0.85 in Q3 2025, 0.85 for Q2 2025, and 0.87 during Q1 2025.